Startup entity
funding is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Aureka Biotechnologies, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Startup story that mention Biological World Model, all published on August 11, 2026.
Last mentioned: Aug 11, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
funding is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Aureka Biotechnologies, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Startup story that mention Biological World Model, all published on August 11, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 7 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Biological World Model. Shared-story counts are live from our verified record — not editorial picks.
Only three years after its founding, Aureka Biotechnologies has secured $100M in Series B funding, led by Granite Asia and a strategic investor, pushing its total raised to nearly $200M. The round highlights intense VC appetite for AI-native biotech platforms aiming to disrupt the $100B+ drug discovery market.
Biological World Model is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
